Brind.

Brainsway Ltd. obtained three FDA-cleared indications for its proprietary Deep TMS platform technology.

2 reports, 1 independent Updated Jul 29

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Brainsway Ltd. obtained three FDA-cleared indications for its proprietary Deep TMS platform technology.

Who's involved

What this event is mainly about

Brainsway Ltd.FDA TMS

Keep exploring

The entities involved

Brainsway Ltd.
Medical technology company

Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
TMS
American metadata company
- Freight Technologies, Inc. develops AI software solutions for logistics, integrating TMS with a highway platform to enable automated carrier onboarding and compliance.Mon 10:38

Coverage

Newest first; wire copies grouped

Jul 30GlobeNewswireBrainsWay to Report Second Quarter 2025 Financial Results on August 13, 2025 BURLINGTON, Mass. and JERUSALEM, July 30, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or th

1 more outlet ran the same wire story

Jul 29manilatimes.net